BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 28122302)

  • 1. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
    Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
    Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
    Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
    Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy.
    Sauraj ; Kumar SU; Kumar V; Priyadarshi R; Gopinath P; Negi YS
    Carbohydr Polym; 2018 May; 188():252-259. PubMed ID: 29525163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination lung cancer chemotherapy: Design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin.
    Li S; Wang L; Li N; Liu Y; Su H
    Biomed Pharmacother; 2017 Nov; 95():548-555. PubMed ID: 28869892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
    Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
    J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
    Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
    Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
    Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.